What is the share price of Fredun Pharmaceuticals Ltd (FREDUN) today?
The share price of FREDUN as on 17th June 2026 is ₹2610.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fredun Pharmaceuticals Ltd (FREDUN) share?
The past returns of Fredun Pharmaceuticals Ltd (FREDUN) share are- Past 1 week: 11.99%
- Past 1 month: 10.34%
- Past 3 months: 59.42%
- Past 6 months: 56.44%
- Past 1 year: 212.71%
- Past 3 years: 192.06%
- Past 5 years: 514.73%
What are the peers or stocks similar to Fredun Pharmaceuticals Ltd (FREDUN)?
The peers or stocks similar to Fredun Pharmaceuticals Ltd (FREDUN) include:What is the market cap of Fredun Pharmaceuticals Ltd (FREDUN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fredun Pharmaceuticals Ltd (FREDUN) is ₹1438.89 Cr as of 17th June 2026.What is the 52 week high and low of Fredun Pharmaceuticals Ltd (FREDUN) share?
The 52-week high of Fredun Pharmaceuticals Ltd (FREDUN) is ₹2699 and the 52-week low is ₹791.What is the PE and PB ratio of Fredun Pharmaceuticals Ltd (FREDUN) stock?
The P/E (price-to-earnings) ratio of Fredun Pharmaceuticals Ltd (FREDUN) is 44.11. The P/B (price-to-book) ratio is 5.17.Which sector does Fredun Pharmaceuticals Ltd (FREDUN) belong to?
Fredun Pharmaceuticals Ltd (FREDUN) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Fredun Pharmaceuticals Ltd (FREDUN) shares?
You can directly buy Fredun Pharmaceuticals Ltd (FREDUN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fredun Pharmaceuticals Ltd
FREDUN Share Price
BSE₹2,610.153.06% (+77.40)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
FREDUN Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
FREDUN Performance & Key Metrics
FREDUN Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 38.39 | 5.17 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.87 | 6.09 | 0.57% |
FREDUN Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
FREDUN Company Profile
Fredun Pharmaceuticals Ltd. is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical formulations. The Company’s products include I V fluids, disposable syringes, infusion sets, surgical gloves and cottons etc.
SUNPHARMA
PE Ratio
38.05
38.05
1Y Return
10.31%
10.31%
Buy Reco %
93.75
93.75
TORNTPHARM
PE Ratio
69.50
69.50
1Y Return
36.47%
36.47%
Buy Reco %
81.48
81.48
CIPLA
PE Ratio
28.13
28.13
1Y Return
10.16%
10.16%
Buy Reco %
62.86
62.86
ZYDUSLIFE
PE Ratio
21.19
21.19
1Y Return
10.83%
10.83%
Buy Reco %
53.57
53.57
DRREDDY
PE Ratio
25.18
25.18
1Y Return
3.78%
3.78%
Buy Reco %
51.52
51.52
FREDUN Sentiment Analysis
FREDUN Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
FREDUN Stock Summary · November 2025
The company is experiencing steady growth, driven by a strategic shift towards becoming a diversified healthcare provider, particularly in the burgeoning pet care market. With plans to enhance manufacturing capacity and optimize operational efficiency, management is focused on innovation and expanding its product range, including nutraceuticals and ethical pet nutrition. The recent acquisition of a pet tech platform aims to create a comprehensive ecosystem for pet wellness, addressing market gaps and fostering brand trust among consumers. As the company navigates international expansion while solidifying its domestic base, it remains committed to sustainable growth through talent acquisition and a robust e-commerce platform that supports small manufacturers. Overall, the outlook is cautiously optimistic, with strong demand for new products and a disciplined approach to long-term vision.
FREDUN Stock Growth Drivers
FREDUN Stock Growth Drivers
7Strong Financial Performance
Fredun Pharmaceuticals Limited has reported significant financial growth, with Q2 FY '26 total income reaching
Expansion and Diversification
The company has successfully transformed into a diversified healthcare entity with a strong presence in
FREDUN Stock Challenges
FREDUN Stock Challenges
0
Hmm, looks like there are nochallenges
FREDUN Forecast
FREDUN Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
FREDUN
FREDUN
Income
Balance Sheet
Cash Flow
Quarterly Normal View
FREDUN Income Statement
FREDUN Income Statement
Quarterly Normal View
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 288.86 | 167.41 | 119.86 | 145.29 | 160.92 | 213.06 | ||||||||
Operating & Other expenses | 0.00 | 0.00 | 251.20 | 150.16 | 102.86 | 122.96 | 134.59 | 184.17 | ||||||||
EBITDA | 0.00 | 0.00 | 37.66 | 17.25 | 17.00 | 22.33 | 26.33 | 28.89 | ||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 3.20 | 1.84 | 1.42 | 1.89 | 1.78 | 3.15 | ||||||||
| PBIT | 0.00 | 0.00 | 34.46 | 15.41 | 15.58 | 20.44 | 24.55 | 25.74 | ||||||||
| Interest & Other Items | 0.00 | 0.00 | 14.23 | 8.15 | 6.53 | 7.73 | 10.55 | 14.49 | ||||||||
| PBT | 0.00 | 0.00 | 20.23 | 7.26 | 9.05 | 12.71 | 14.00 | 11.25 | ||||||||
| Taxes & Other Items | 0.00 | 0.00 | 6.49 | 1.26 | 2.27 | 3.27 | 3.52 | 0.47 | ||||||||
| Net Income | 0.00 | 0.00 | 13.74 | 6.00 | 6.78 | 9.44 | 10.48 | 10.78 | ||||||||
| EPS | 0.00 | 0.00 | 29.09 | 12.71 | 14.33 | 19.98 | 22.19 | 19.70 |
FREDUN Company Updates
FREDUN Stock Peers
FREDUN Past Performance & Peer Comparison
FREDUN Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fredun Pharmaceuticals Ltd | 44.11 | 5.17 | — |
| Sun Pharmaceutical Industries Ltd | 38.05 | 6.03 | 0.88% |
| Torrent Pharmaceuticals Ltd | 69.50 | 8.55 | 0.86% |
| Cipla Ltd | 28.13 | 3.16 | 0.96% |
FREDUN Stock Price Comparison
Compare FREDUN with any stock or ETFCompare FREDUN with any stock or ETF
FREDUN
FREDUN Holdings
FREDUN Shareholdings
FREDUN Promoter Holdings Trend
FREDUN Promoter Holdings Trend
FREDUN Institutional Holdings Trend
FREDUN Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 1.78%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
FREDUN Shareholding Pattern
FREDUN Shareholding Pattern
FREDUN Shareholding History
FREDUN Shareholding History
Foreign Institutions
smallcases containing FREDUN stock
smallcases containing FREDUN stock
Looks like this stock is not in any smallcase yet.
FREDUN Events
FREDUN Events
FREDUN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
FREDUN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
FREDUN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
FREDUN has not given any dividends in last 5 years
FREDUN Upcoming Dividends
FREDUN Upcoming Dividends
Cash Dividend
Ex DateEx DateJun 23, 2026
Final
Final | Div/Share: ₹0.70
Dividend/Share
₹0.70
Ex DateEx Date
Jun 23, 2026
FREDUN Past Dividends
FREDUN Past Dividends
Cash Dividend
Ex DateEx DateSep 23, 2025
Final
Final | Div/Share: ₹0.70
Dividend/Share
₹0.70
Ex DateEx Date
Sep 23, 2025
Cash Dividend
Ex DateEx DateSep 23, 2024
Final
Final | Div/Share: ₹0.70
Dividend/Share
₹0.70
Ex DateEx Date
Sep 23, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Final
Final | Div/Share: ₹0.70
Dividend/Share
₹0.70
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 16, 2021
Final
Final | Div/Share: ₹0.70
Dividend/Share
₹0.70
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateSep 16, 2019
Final
Final | Div/Share: ₹0.65
Dividend/Share
₹0.65
Ex DateEx Date
Sep 16, 2019
FREDUN Stock News & Opinions
FREDUN Stock News & Opinions
Articles & Videos
Corporate
Corporate
Fredun Pharmaceuticals to convene AGMFredun Pharmaceuticals announced that the 39th Annual General Meeting(AGM) of the company will be held on 30 June 2026.
1 week agoCapital Market - Live
Earnings
Earnings
Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarterNet profit of Fredun Pharmaceuticals rose 79.67% to Rs 10.78 crore in the quarter ended March 2026 as against Rs 6.00 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025. For the full year,net profit rose 65.25% to Rs 32.62 crore in the year ended March 2026 as against Rs 19.74 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales210.41165.44 27 633.33451.71 40 OPM %13.7310.43 -13.9212.16 - PBDT14.409.10 58 55.2432.53 70 PBT11.257.26 55 47.0027.49 71 NP10.786.00 80 32.6219.74 65 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Corporate
Board of Fredun Pharmaceuticals approves bonus issue of 2:1The board of Fredun Pharmaceuticals at its meeting held on May 25, 2026, wherein the audited financial results for Q4 and FY26 were approved, has recommended the issuance of bonus shares in the ratio of 2:1, i.e. 2 fully paid-up equity shares of Rs 10 each for every 1 existing equity share of Rs 10 each, to eligible shareholders and warrant holders as on the record date, subject to shareholder approval.
3 weeks agoCapital Market - Live
Corporate
Corporate
Board of Fredun Pharmaceuticals recommends final dividendFredun Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 0.7 per equity Share (i.e. 7%) , subject to the approval of the shareholders.
3 weeks agoCapital Market - Live
Earnings
Earnings
Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarterNet profit of Fredun Pharmaceuticals rose 56.58% to Rs 11.07 crore in the quarter ended March 2026 as against Rs 7.07 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025. For the full year,net profit rose 59.59% to Rs 33.21 crore in the year ended March 2026 as against Rs 20.81 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales210.41165.44 27 633.33451.71 40 OPM %13.8510.54 -14.9712.20 - PBDT14.659.29 58 55.5032.72 70 PBT11.548.04 44 47.5928.27 68 NP11.077.07 57 33.2120.81 60 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Corporate
Fredun Pharmaceuticals to announce Quarterly ResultFredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 May 2026.
1 month agoCapital Market - Live
Corporate
Corporate
Fredun Pharmaceuticals sets up its 5th manufacturing unit in PalgharFredun Pharmaceuticals has announced the establishment of a new manufacturing facility in Palghar, Maharashtra, marking the addition of its fifth facility.
1 month agoCapital Market - Live
Corporate
Corporate
Fredun Pharmaceuticals allots 40,000 equity shares on conversion of warrantsFredun Pharmaceuticals has allotted 40,000 equity shares on conversion of warrants on 09 April 2026.
2 months agoCapital Market - Live
Earnings
Earnings
Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarterNet profit of Fredun Pharmaceuticals rose 96.62% to Rs 10.48 crore in the quarter ended December 2025 as against Rs 5.33 crore during the previous quarter ended December 2024. Sales rose 57.04% to Rs 159.93 crore in the quarter ended December 2025 as against Rs 101.84 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales159.93101.84 57 OPM %16.4612.98 - PBDT15.788.22 92 PBT14.007.13 96 NP10.485.33 97 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Fredun Pharmaceuticals to convene board meetingFredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live
4 months agoCapital Market - Live
In last 6 months, promoter holding in the company has decreased by 4.77%
Pledged promoter holdings is insignificant